Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Go back to Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention| (NASDAQ: JAGX) | Delayed: 1.05 -0.28 (21.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.33 | 52 Week High | $4.60 | |||
| Open | $1.33 | 52 Week Low | $0.81 | |||
| Day High | $1.33 | P/E | N/A | |||
| Day Low | $0.97 | EPS | $0.00 | |||
| Volume | 217,465 | |||||
